AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2019
May 15, 2019
33483_dirs_2019-05-15_0f346a9f-373a-4dcc-a31f-b6d016aba64e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-05-07
Reporting Person: Donohue Ann K. (Controller)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1216 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $10.89 | 2027-03-22 | Common Stock (5100.0) | Direct | |
| Stock Option (Right to Buy) | $17.47 | 2027-06-15 | Common Stock (1108.0) | Direct | |
| Stock Option (Right to Buy) | $12.46 | 2028-06-11 | Common Stock (10000.0) | Direct | |
| Stock Option (Right to Buy) | $2.6 | 2029-01-06 | Common Stock (25000.0) | Direct |
Footnotes
F1: This option vested as to 25% on September 12, 2017. The remainder of the underlying shares vest in 36 equal monthly installments thereafter.
F2: This option vested as to 25% on June 16, 2018. The remainder of the underlying shares vest in 36 equal monthly installments thereafter.
F3: This option will vest as to 25% on June 12, 2019. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.
F4: This option will vest as to 25% on January 7, 2020. The remainder of the underlying shares vest in 36 equal monthly installments thereafter.